Market News & Trends
Teva's Potential $40-Billion Acquisition Could Transform Generics Space
Teva Pharmaceutical Industries’ recent $40.1-billion offer to purchase Netherlands-based Mylan, which is crucially contingent on Mylan not consummating its offer to acquire Irish firm Perrigo,…
Pipeline Advancements & Asset Acquisitions Fueled Mid-Cap Biotech Research & Development Spend in 2014
The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a…
Q1 2015 Global Pharma, Medical & Biotech Trend Report
Mergermarket has released its Global Pharma, Medical & Biotech (PMB) trend report for the first quarter (Q1) of 2015. Take a look at the full…
New Jersey Pharmaceutical Association for Science & Technology Celebrates 60th Anniversary
The New Jersey Pharmaceutical Association for Science and Technology (NJPhAST) will be launching the celebration of its 60th anniversary at its September 17th meeting…
Drug R&D Costs: $1.7 Billion & Rising
The significant costs of developing new, life-saving drugs and treatments has reached over $1.7 billion per drug over a span of 10-12 years. The mounting…
Recipharm Makes Strategic Investment in Synthonics
Recipharm recently announced it has made an equity investment in Synthonics Inc and purchased $2 million of preferred stock in the company. A further $2…
Firm Raises $2.8 Billion for NEA 15 Fund; $350 Million for Opportunity Fund
Global venture capital firm New Enterprise Associates, Inc. recently announced the close of its 15th fund with $2.8 billion in committed capital to its core…
West Pharmaceutical Services Appoints New CEO
West Pharmaceutical Services, Inc. recently announced that Eric M. Green has been appointed the company's Chief Executive Officer, succeeding Donald E. Morel, Jr., PhD, current…
Catalent Completes $52-Million Expansion
Catalent Pharma Solutions recently announced the opening of a large-scale expansion at its Winchester, KY, manufacturing facility, which has seen the doubling of its footprint…
Aduro Biotech Announces Pricing of IPO; Expects $107 Million
Aduro Biotech, Inc. recently announced the pricing of its initial public offering of 7,000,000 shares of common stock at a price to the public of…
Celgene & Mesoblast Enter $45-Million Agreement
Mesoblast Limited recently announced it has entered into an agreement with US-based Celgene Corporation, a global biopharmaceutical company engaged in the development and commercialization of…
Melanoma Treatment Market Value to More Than Quadruple to $5.64 Billion
The global treatment market for melanoma will expand more than four-fold in value from $1.34 billion in 2013 to reach an estimated $5.64 billion by…
Edge Therapeutics Raises $72.5 Million to Advance Pipeline
Edge Therapeutics recently announced it has raised approximately $72.5 million in gross proceeds from two recently completed private financing rounds. The most recent round, a…
Protea Announces Acquisition Agreement to Develop & Market New Services
Protea Biosciences Group, Inc. recently announced it has entered into an agreement dated as of March 31, 2015, for the purchase of vivoPharm Pty Ltd.,…
PhoreMost Ltd Founded to Identify New Druggable Targets for Therapeutics
PhoreMost Ltd has been founded to identify new druggable targets for cancer and other unmet diseases. Based in Cambridge, UK, PhoreMost announced it has successfully…
Foster Polymer Distribution Announces Official Partnership
Foster Polymer Distribution, a business unit of Foster Corporation specializing in the distribution of medical polymers and additives, recently announced its official partnership with Mitsubishi…
Catalent Pharma Solutions Joins Pharma & Biopharma Outsourcing Association
The Pharma & Biopharma Outsourcing Association (PBOA) recently announced that Catalent Pharma Solutions has joined the PBOA as a Sustaining Member. Cornell Stamoran, Vice President,…
Alzheon Announces $10-Million Financing to Advance Lead Drug Candidate
Alzheon, Inc. recently announced it has closed a $10-million Series A financing round. This equity financing was led by Ally Bridge Group and included investments…
Top Mid-Cap Biotech Companies Increased Revenues to $26.5 Billion in 2014
The combined total revenues for the peer group of 35 mid-cap biotech companies increased from $24.8 billion in 2013 to $26.5 billion in 2014, representing…
PlasmaTech Biopharmaceuticals' Partner Receives Marketing Approval
PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI) recently announced that its Korean marketing partner, Hanmi Pharmaceutical Co., Ltd has received marketing approval in Korea from the country's…
